Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for OptimizeRx (OPRX) over the last 17 years, with Q3 2025 value amounting to $18.6 million.

  • OptimizeRx's Shares Outstanding (Weighted Average) rose 137.89% to $18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.6 million, marking a year-over-year increase of 137.89%. This contributed to the annual value of $18.3 million for FY2024, which is 682.13% up from last year.
  • According to the latest figures from Q3 2025, OptimizeRx's Shares Outstanding (Weighted Average) is $18.6 million, which was up 137.89% from $18.5 million recorded in Q2 2025.
  • OptimizeRx's Shares Outstanding (Weighted Average)'s 5-year high stood at $18.6 million during Q3 2025, with a 5-year trough of $16.1 million in Q1 2021.
  • In the last 5 years, OptimizeRx's Shares Outstanding (Weighted Average) had a median value of $17.9 million in 2022 and averaged $17.7 million.
  • In the last 5 years, OptimizeRx's Shares Outstanding (Weighted Average) soared by 1837.72% in 2021 and then tumbled by 603.97% in 2023.
  • Over the past 5 years, OptimizeRx's Shares Outstanding (Weighted Average) (Quarter) stood at $17.2 million in 2021, then rose by 3.23% to $17.8 million in 2022, then fell by 3.71% to $17.1 million in 2023, then increased by 6.82% to $18.3 million in 2024, then grew by 1.55% to $18.6 million in 2025.
  • Its last three reported values are $18.6 million in Q3 2025, $18.5 million for Q2 2025, and $18.5 million during Q1 2025.